You are here: Industry Insights > COVID-19

News List

Remote patient monitoring to be most impactful trend in pharma industry in 2021 expresspharma
January 21, 2021
Ongoing COVID-19 lockdowns and requirements of social distancing have swiftly pushed healthcare provision and patient monitoring towards remote options.
InVixa announces licensing deal with University of California, Davis for the commercialization of novel inhaled statins for the treatment of COVID-19 prnewswire
January 20, 2021
InVixa Inc, a biopharmaceutical start-up developing inhaled statins to treat COVID-19, announced today an exclusive licensing deal with the University of California, Davis, a leading US academic and medical institution.
Gritstone Advances Second Generation COVID-19 Vaccine americanpharmaceuticalreview
January 20, 2021
Gritstone Oncology is advancing development of a second-generation vaccine against SARS-CoV-2, the virus that causes COVID-19, with potential for both prolonged protection and potency against Spike mutants.
ARUP Sequencing Specimens Able to Detect the UK Variant of COVID-19 americanpharmaceuticalreview
January 20, 2021
ARUP Laboratories announced it is sequencing variants of SARS-CoV-2 in specimens positive for COVID-19 to enable detection of the more contagious "United Kingdom (UK) variant" of the virus.
Syntegra collaborates with US NIH to increase access to Covid-19 data pharmaceutical-technology
January 20, 2021
Syntegra and the US National Institutes of Health (NIH) have collaborated to expand access to the largest set of Covid-19 patient records using the former’s AI-enabled synthetic data technology.
Metformin use reduces risk of death for patients with COVID-19 and diabetes worldpharmanews
January 19, 2021
Use of the diabetes drug metformin - before a diagnosis of COVID-19 - is associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes, according to a racially diverse study at the University of Alabama at Birmingham ...
US could purchase over 1.5 million doses of Regeneron’s COVID-19 antibody cocktail europeanpharmaceuticalreview
January 19, 2021
The additional doses of casirivimab and imdevimab, two monoclonal antibodies, will be used in non-hospitalised COVID-19 patients.
Trial to evaluate inhaled COVID-19 therapy finishes enrolment europeanpharmaceuticalreview
January 19, 2021
The pilot study will determine whether an inhaled formulation of ensifentrine can expedite the recovery of patients hospitalised with COVID-19.
Grifols Begins COVID-19 Plasma Treatment Trial contractpharma
January 19, 2021
Treatment could be used for people who test positive for COVID-19, avoiding hospitalization due to the progression of the disease, complementing the vaccine.
South Africa to get nine million doses of J&J vaccine: Business Day expresspharma
January 19, 2021
South Africa, which has yet to receive its first coronavirus vaccine, has been promised nine million doses by Johnson & Johnson, the Business Day newspaper reported, citing a health ministry spokeswoman.